MDVN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MDVN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medivation's Average Total Inventories for the quarter that ended in Jun. 2016 was $0 Mil. Medivation's Revenue for the three months ended in Jun. 2016 was $206 Mil. Medivation's Inventory-to-Revenue for the quarter that ended in Jun. 2016 was 0.00.
Medivation's Inventory-to-Revenue for the quarter that ended in Jun. 2016 stayed the same from Mar. 2016 (0.00) to Mar. 2016 (0.00)
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Inventory Turnover measures how fast the company turns over its inventory within a year.
The historical data trend for Medivation's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medivation Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
Inventory-to-Revenue | Get a 7-Day Free Trial | - | - | - | - | - |
Medivation Quarterly Data | ||||||||||||||||||||
Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | |
Inventory-to-Revenue | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Medivation's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Medivation's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Medivation's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medivation's Inventory-to-Revenue for the fiscal year that ended in Dec. 2015 is calculated as
Inventory-to-Revenue (A: Dec. 2015 ) | |||||||
= | Average Total Inventories | / | Revenue | ||||
= | ( (Total Inventories (A: Dec. 2014 ) | + | Total Inventories (A: Dec. 2015 )) | / | count ) | / | Revenue (A: Dec. 2015 ) |
= | ( (0 | + | 0) | / | 1 ) | / | 943.258 |
= | 0 | / | 943.258 | ||||
= | 0.00 |
Medivation's Inventory-to-Revenue for the quarter that ended in Jun. 2016 is calculated as
Inventory-to-Revenue (Q: Jun. 2016 ) | |||||||
= | Average Total Inventories | / | Revenue | ||||
= | ( (Total Inventories (Q: Mar. 2016 ) | + | Total Inventories (Q: Jun. 2016 )) | / | count ) | / | Revenue (Q: Jun. 2016 ) |
= | ( (0 | + | 0) | / | 1 ) | / | 206.165 |
= | 0 | / | 206.165 | ||||
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medivation (NAS:MDVN) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenueLikewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenueMore Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Medivation's Days Inventory for the three months ended in Jun. 2016 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Jun. 2016 ) | / | Cost of Goods Sold (Q: Jun. 2016 ) | * | Days in Period |
= | 0 | / | 0 | * | 365 / 4 | |
= |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medivation's Inventory Turnover for the quarter that ended in Jun. 2016 is calculated as
Inventory Turnover | = | Cost of Goods Sold (Q: Jun. 2016 ) | / | Average Total Inventories (Q: Jun. 2016 ) |
= | 0 | / | 0 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Medivation's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
W Anthony Vernon | director | C/O AXOVANT SCIENCES, INC., 320 WEST 37TH STREET, NEW YORK NY 10018 |
Marion Mccourt | officer: Chief Operating Officer | C/O AXOVANT SCIENCES, INC., 320 WEST 37TH STREET, 5TH FLOOR, NEW YORK NY 10018 |
Tseli Lily Yang | officer: VP, Finance and Accounting | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
Mohammad Hirmand | officer: Interim Chief Medical Officer | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
David Hung | director, officer: President and CEO | C/O AXOVANT SCIENCES, INC., 320 WEST 37TH STREET, 5TH FLOOR, NEW YORK NY 10018 |
Dawn Svoronos | director | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
Wendy L Yarno | director | |
Jennifer Jarrett | officer: Chief Financial Officer | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
Kim D Blickenstaff | director | C/O MEDIVATION, INC., 201 SPEAR STREET, 3RD FLOOR, SAN FRANCISCO CA 94105 |
Powell Andrew Kenneth William | officer: SVP, General Counsel & Crp Sec | C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Patrick Machado | director | 201 SPEAR STREET, 3RD FLOOR, SAN FRANCISCO CA 94107 |
Kathryn E Falberg | director | C/O AXOVANT SCIENCES, INC., 320 WEST 37TH STREET, 5TH FLOOR, NEW YORK NY 10018 |
Rick Bierly | officer: CFO (former) | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
Joseph M Lobacki | officer: Chief Commercial Officer | C/O MICROMET, INC., 9201 CORPORATE BLVD., SUITE 400, ROCKVILLE MD 20850 |
Jennifer J Rhodes | officer: GC & Corporate Secretary | C/O ADAMAS PHARMACEUTICALS INC., 1900 POWELL ST., SUITE 750, EMERYVILLE CA 94608 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 12-09-2009
By Holly LaFon Holly LaFon • 08-22-2012
By GuruFocus Research GuruFocus Editor • 02-09-2011
By Tiziano Frateschi Tiziano Frateschi • 05-20-2016
By GuruFocus Research GuruFocus Editor • 01-21-2010
By GuruFocus Research GuruFocus Editor • 09-11-2009
By Jimmy Xiao Jimmy Xiao • 01-26-2016
By GuruFocus Research GuruFocus Editor • 09-11-2009
By TipRanks TipRanks • 12-23-2014
By GuruFocus Research GuruFocus Editor • 12-09-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.